JDOC logo

JDOCJPMorgan Healthcare Leaders ETF

$57.33
$0.3893
(0.68%)
Today
Updated: 12:59 PM EDT
Vol772.00
52W High$59.69
52W Low$48.35
News
all
press releases
News Placeholder
Why Did RARE Stock Plunge Over 41% Today?
Ultragenyx Pharmaceutical announced disappointing results from its Phase 3 studies for the setrusumab (UX143) in the Osteogenesis Imperfecta (OI) program.
Stocktwits
News Placeholder
MoonLake Immunotherapeutics Stock Draws Wall Street Attention Post Monday’s Plunge: Retail Sees Significant Upside
Needham analyst Serge Belanger lowered the firm's price target on the stock to $20 from $66 but kept a ‘Buy’ rating on the shares.
Stocktwits
News Placeholder
Merck To Acquire Verona For $10B In Bid To Expand Cardio-Pulmonary Pipeline
Merck will acquire Verona for $107 per American Depository Share (ADS), each of which represents eight Verona Pharma ordinary shares, for a total transaction value of approximately $10 billion.
Stocktwits
<
...
1
>

Advertisement|Remove ads.